Member Spotlight

S. Nassir Ghaemi, MD, MPH; Ira D. Glick, MD,*; and James M. Ellison, MD, MPH A Commentary on Existential Psychopharmacologic Clinical Practice: Advocating a Humanistic Approach to the “Med Check”

 

Michael E. Thase, MD A Note from the ASCP President

 

Trisha Suppes, MD, PhD, Depression With Mixed Features in Major Depressive Disorder: A New Diagnosis or There All Along?

 

Ahmed N. Hassan, MD, FRCPC, MPH, Patients With Alcohol Use Disorder Co-Occurring With Depression and Anxiety Symptoms: Diagnostic and Treatment Initiation Recommendations January 2018

 

Amanda Tinkelman, MD, Emily A. Hill, MD, Kristina M. Deligiannidis, MD, Management of New Onset Psychosis in the Postpartum Period November 2017

 

Joseph F. Goldberg, MD, Do You Order Pharmacogenetic Testing? Why? August 2017

 

Jose M. Rubio, MD, & Christoph U. Correll, MD, Duration and Relevance of Untreated Psychiatric Disorders, 2: Nonpsychotic Psychiatric Disorders and Substance Use Disorders. May 2017

 

Jose M. Rubio, MD, & Christoph U. Correll, MD, Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic Disorders. April 2017

 

Arif Khan, MD, High Risk of Death Participating in Drug Trials with a Psychiatric Illness. August 2013